1626 results
Nightmares in TAVI: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.
Imaging for aortic valve disease
18 Feb 2024 – From PCR Tokyo Valves 2024
Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...
New devices for aortic intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.
Rapid-fire - Bailout in TAVI
18 Feb 2024 – From PCR Tokyo Valves 2024
As TAVI is never risk-free, learn about bailout techniques to counter various complications through this series of rapid-fire case submissions. This session explores cases such as a transcatheter aortic valve distortion following cardiopulmonary resuscitation, acute transcatheter aortic valve migration into the left ventricle, and valve embolization.
In remembrance of Alain Cribier
17 Feb 2024
It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...
Valve-in-Valve
17 Feb 2024 – From PCR Tokyo Valves 2024
Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
Rapid-fire - Complications in SHD interventions
17 Feb 2024 – From PCR Tokyo Valves 2024
Learn more about complications related to structural heart disease interventions through this rapid-fire series of cases. Discover cases such as a cardiac arrest due to coronary artery obstruction two days after TAVI using a balloon-expandable valve, an aortic stenosis case switched to surgery due to severe...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
Plan your moves: strategies for valves re-intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Edwards Lifesciences focuses on recognising key elements of valve design that impact ability to host future valves re-interventions, learning how to achieve repeatable implant experiences for the index valve and second valve, and identifying strategies to simplify transcatheter heart valve redo...
Late-Breaking Trial session
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...
PCI after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, examine selected cases of percutaneous coronary intervention after TAVI. Explore the case of a successful bailout PCI with en-face view for sinus sequestration after self-expandable TAVI, learn about best management of previous implanted chimney stent during TAVI, and more.
TAV-in-TAV interventions: a new frontier in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...
Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...
Rapid-fire - TAVI concomitant with CAD
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!
Learn the procedure strategy - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Medtronic focuses on learning what characteristic valves should be used to treat aortic stenosis patients with low calcification or with extremely small native aortic annuluses, and what to pay attention to during the procedure.
Selection of the 2024 best clinical cases
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding clinical cases from PCR Tokyo Valves 2024, including a nightmare case with bicuspid aortic valve, pharmaco-invasive management of mechanical valve thrombus with cardiogenic shock, and a TAVR-in-TAVR challenge.
Selection of the 2024 best abstracts
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding abstracts from PCR Tokyo Valves 2024, such as a study on the disparity in impact of bleeding after TAVI on long-term mortality between Asian and Nordic population, learning about two-year clinical outcomes of staged transcatheter mitral edge-to-edge repair after TAVR, and a...
Rapid-fire - Valve-in-Valve TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, gain valuable insights into valve-in-valve TAVI from a rapid-fire series of scenarios that cover structural valve deterioration after SAPIEN 3 implantation, a successful aortic valve-in-valve with balloon valve fracture and coronary protection, and TAV-in-SAV for an extremely small failed surgical valve.